Middle East & Africa Autoimmune Diagnostics Market Research Report – Segmented By Test Type, Disease Type, End User and Country (KSA, UAE, Israel, rest of GCC countries, South Africa, Ethiopia, Kenya, Egypt, Sudan, rest of MEA) – Industry Size, Share, Trends, Growth, Forecast (2024 to 2029)
MEA Autoimmune Diagnostics Market Size (2023 to 2028)
The size of the Middle East and Africa Autoimmune Diagnostics Market was worth USD 0.60 billion in 2023 and estimated to reach USD 0.70 billion by the end of 2028, growing at a CAGR of 3.108% between 2023 to 2028.
Autoimmune diseases are an active hyperimmune response against their own body tissues and cells. Due to mergers and acquisitions that provide an increasing opportunity in this region. The most common autoimmune diseases include rheumatoid arthritis, type 1 diabetes, and multiple sclerosis.
The Middle East & Africa market is driven by the increasing prevalence of autoimmune disorders improving healthcare infrastructure.
Cost issues and problems of skilled manpower are the factors that hinder the growth of the market.
This research report is on the Middle East and Africa Autoimmune diagnostics market has been segmented & sub-segmented into the following categories:
By Test Type:
- Autoantibody Tests
- Antinuclear Antibody Tests
- Complete Blood Count (CBC)
- C-reactive protein (CRP)
- Comprehensive Metabolic panel
- Urinalysis
- Erythrocyte Sedimentation Rate (ESR)
- Others
By Disease Type:
- Localized autoimmune disease diagnostics
- Graves' Disease
- Hashimoto's Thyroiditis
- Multiple Sclerosis
- Type 1 diabetes
- Psoriasis
- Others
- Systemic autoimmune disease diagnostics
- Rheumatoid Arthritis (RA)
- Ankylosing Spondylitis
- Systemic Lupus Erythematosus (SLE)
By End User:
- Hospitals
- Research Centres
- Diagnostic Laboratories
By Country:
- KSA
- UAE
- Israel
- rest of GCC countries
- South Africa
- Ethiopia
- Kenya
- Egypt
- Sudan
- rest of MEA
Companies like Bio-Rad, Siemens Healthcare, Abbott Laboratories, Crescendo Bioscience, Roche Diagnostics SQI Diagnostics, AESKU Diagnostics, INOVA Diagnostics Inc., BioMerieux SA, Beckman Coulter Inc., Hemagen Diagnostics, Quest Diagnostics, Eli Lilly and GlaxoSmithKline Plc are playing a notable role in the MEA autoimmune diagnostics market.
Related Reports
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 1600
Didn’t find what you’re looking for?
TALK TO OUR ANALYST TEAM
Need something within your budget?
NO WORRIES! WE GOT YOU COVERED!
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: [email protected]